<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00583401</url>
  </required_header>
  <id_info>
    <org_study_id>AGA-011</org_study_id>
    <secondary_id>G060145</secondary_id>
    <nct_id>NCT00583401</nct_id>
    <nct_alias>NCT00557479</nct_alias>
  </id_info>
  <brief_title>PFO ACCESS Registry</brief_title>
  <official_title>Patent Foramen Ovale Closure With the AMPLATZER PFO OCCLUDER in Patients With Recurrent Cryptogenic Stroke Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale Who Have Failed Conventional Drug Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Jude Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Jude Medical</source>
  <brief_summary>
    <textblock>
      Closure of Patent Foramen Ovale with the AMPLATZERÂ® PFO OCCLUDER in patients with at least
      two cryptogenic strokes due to presumed paradoxical embolism through a patent foramen ovale
      and who have failed conventional therapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of the PFO Access Registry is to allow access to the AMPLATZER PFO
      Occluder in subjects with a PFO who have already experienced at least two cryptogenic strokes
      due to presumed paradoxical embolism through a patent foramen ovale and who have failed
      conventional drug therapy.
    </textblock>
  </detailed_description>
  <overall_status>No longer available</overall_status>
  <study_type>Expanded Access</study_type>
  <condition>Patent Foramen Ovale</condition>
  <condition>Stroke</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Device closure with the AMPLATZER PFO Occluder</intervention_name>
    <description>Device closure with the AMPLATZER PFO Occluder</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patent foramen ovale (PFO); recurrent cryptogenic stroke; failed antiplatelet/anticoagulant
        therapy

        Exclusion Criteria:

        International normalized ration (INR) outside of 2-3; intracardiac thrombus (subjects may
        be enrolled after resolution of thrombus)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 21, 2007</study_first_submitted>
  <study_first_submitted_qc>December 21, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 31, 2007</study_first_posted>
  <last_update_submitted>February 16, 2018</last_update_submitted>
  <last_update_submitted_qc>February 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>PFO</keyword>
  <keyword>stroke</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Foramen Ovale, Patent</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

